摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3-hydroxyphenyl)nitrobenzene | 367268-90-4

中文名称
——
中文别名
——
英文名称
2-(3-hydroxyphenyl)nitrobenzene
英文别名
2'-Nitro-biphenyl-3-OL;3-(2-nitrophenyl)phenol
2-(3-hydroxyphenyl)nitrobenzene化学式
CAS
367268-90-4
化学式
C12H9NO3
mdl
——
分子量
215.208
InChiKey
MZTIZIKPVMSKHS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    16
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    66
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(3-hydroxyphenyl)nitrobenzene 在 10percent Pd/C 咪唑 、 benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate 、 氢气N,N-二异丙基乙胺 作用下, 以 乙醇二氯甲烷乙酸乙酯N,N-二甲基甲酰胺 为溶剂, 20.0 ℃ 、101.33 kPa 条件下, 反应 3.25h, 生成 {1-[3'-(tert-butyl-dimethyl-silanyloxy)-biphenyl-2-ylcarbamoyl]-3-methylsulfanyl-propyl}-carbamic acid tert-butyl ester
    参考文献:
    名称:
    3-Aminopyrrolidinone Farnesyltransferase Inhibitors:  Design of Macrocyclic Compounds with Improved Pharmacokinetics and Excellent Cell Potency
    摘要:
    A series of macrocyclic 3-aminopyrrolidinone farnesyltransferase inhibitors (FTIs) has been synthesized. Compared with previously described linear 3-aminopyrrolidinone FTIs such as compound 1, macrocycles such as 49 combined improved pharmacokinetic properties with a reduced potential for side effects. In dogs, oral bioavailability was good to excellent, and increases in plasma half-life were due to attenuated clearance. It was observed that in vivo clearance correlated with the flexibility of the molecules and this concept proved useful in the design of FTIs that exhibited low clearance, such as FTI 78. X-ray crystal structures of compounds 49 and 66 complexed with farnesyltransferase (FTase)-farnesyl diphosphate (FPP) were determined, and they provide details of the key interactions in such ternary complexes. Optimization of this 3-aminopyrrolidinone series of compounds led to significant increases in potency, providing 83 and 85, the most potent inhibitors of FTase in cells described to date.
    DOI:
    10.1021/jm010531d
  • 作为产物:
    描述:
    2-(3-甲氧基苯基)硝基苯三溴化硼 作用下, 以 二氯甲烷 为溶剂, 反应 18.0h, 以98%的产率得到2-(3-hydroxyphenyl)nitrobenzene
    参考文献:
    名称:
    3-Aminopyrrolidinone Farnesyltransferase Inhibitors:  Design of Macrocyclic Compounds with Improved Pharmacokinetics and Excellent Cell Potency
    摘要:
    A series of macrocyclic 3-aminopyrrolidinone farnesyltransferase inhibitors (FTIs) has been synthesized. Compared with previously described linear 3-aminopyrrolidinone FTIs such as compound 1, macrocycles such as 49 combined improved pharmacokinetic properties with a reduced potential for side effects. In dogs, oral bioavailability was good to excellent, and increases in plasma half-life were due to attenuated clearance. It was observed that in vivo clearance correlated with the flexibility of the molecules and this concept proved useful in the design of FTIs that exhibited low clearance, such as FTI 78. X-ray crystal structures of compounds 49 and 66 complexed with farnesyltransferase (FTase)-farnesyl diphosphate (FPP) were determined, and they provide details of the key interactions in such ternary complexes. Optimization of this 3-aminopyrrolidinone series of compounds led to significant increases in potency, providing 83 and 85, the most potent inhibitors of FTase in cells described to date.
    DOI:
    10.1021/jm010531d
点击查看最新优质反应信息

文献信息

  • Dynamic Kinetic Resolution of Biaryl Atropisomers via Peptide-Catalyzed Asymmetric Bromination
    作者:Jeffrey L. Gustafson、Daniel Lim、Scott J. Miller
    DOI:10.1126/science.1188403
    日期:2010.6.4
    widespread use of axially chiral, or atropisomeric, biaryl ligands in modern synthesis and the occurrence of numerous natural products exhibiting axial chirality, few catalytic methods have emerged for the direct asymmetric preparation of this compound class. Here, we present a tripeptide-derived small-molecule catalyst for the dynamic kinetic resolution of racemic biaryl substrates. The reaction proceeds
    选择性纺丝联芳基化合物,其中两个苯环通过单键连接,表现出一种有趣的手性,称为阻转异构。如果庞大的取代基阻止了环围绕连接键的相互旋转,则可以分离出两种异构体,它们仅在一个环旋转离开另一个平面的方向上不同。此特征可用于不对称催化的配体设计,并且也出现在许多多环天然产物中。然而,单一异构体的选择性合成是困难的。古斯塔夫森等人。(p. 1251) 现在表明,一种简单的三肽衍生物可作为一种有效的催化剂,通过选择性溴化在一个方向上捕获自由旋转的前体;大的溴取代基然后抑制进一步旋转。一种简单的催化剂将类抗生素分子转化为近乎单一的手性形式。尽管在现代合成中广泛使用轴向手性或阻转异构的联芳基配体,并且出现了许多表现出轴向手性的天然产物,但很少出现用于直接不对称制备此类化合物的催化方法。在这里,我们提出了一种三肽衍生的小分子催化剂,用于外消旋联芳基底物的动态动力学拆分。该反应通过使用简单溴化试剂的阻转异构体选
  • Synthesis of nitrodienes, nitrostyrenes, and nitrobiaryls through palladium-catalyzed couplings of β-nitrovinyl and o-nitroaryl thioethers
    作者:Gardner S. Creech、Ohyun Kwon
    DOI:10.1039/c3sc50773d
    日期:——
    A highly efficient, base-free, mild protocol for the palladium-catalyzed, copper-activated desulfitative couplings of vinyl and aryl β-nitrothioethers generates a wide variety of conjugated nitroorganics. Orthogonality to traditional Suzuki–Miyaura coupling is demonstrated, as well as synthetic utility, through reductive Cadogan cyclization, for the formation of indoles, carbazoles, and pyrroles.
    一种高效、无基地、温和的方案,用于钯催化、铜激活的乙烯和芳基β-硝基硫醚的去硫酸酯偶联,可生成多种共轭硝基有机化合物。证明了与传统的铃木-宫浦偶联反应的正交性,以及通过还原性卡多根环化合成吲哚、卡巴唑和吡咯的合成应用。
  • Inhibitors of prenyl-protein transferase
    申请人:——
    公开号:US20020123497A1
    公开(公告)日:2002-09-05
    The present invention is directed to peptidomimetic macrocyclic compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting prenyl-protein transferase and the prenylation of the oncogene protein Ras.
    本发明涉及抑制蛋白质脂基转移酶和癌基因蛋白Ras的蛋白质肽模拟大环化合物。该发明还涉及包含本发明化合物的化疗组合物以及抑制蛋白质脂基转移酶和癌基因蛋白Ras脂基化的方法。
  • INHIBITORS OF PRENYL-PROTEIN TRANSFERASE
    申请人:Merck & Co., Inc.
    公开号:EP1214326A1
    公开(公告)日:2002-06-19
  • US6441017B1
    申请人:——
    公开号:US6441017B1
    公开(公告)日:2002-08-27
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐